Novogen Limited KZIA
9.51
(0.27)
(2.76%)
as of 25 Sep
- Market cap
- $111.8M
- P/E
- 0.0×
Follow KZIA
| Older periods | Jun '24 | Dec '24 | Jun '25 | Dec '25 | |
|---|---|---|---|---|---|
| P/E ratio |
+8 more quarters Free account |
— | — | — | — |
| EV/Sales | — | — | — | — | |
| EV/FCF | — | — | — | — | |
| Quick Ratio | 0.22 | 0.19 | 0.32 | 2.86 | |
| Current Ratio | 0.24 | 0.21 | 0.35 | 2.87 | |
| Net Debt/EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | |
| Debt/Assets | 2.94% | 0.79% | 6.52% | 0.14% | |
| Debt/Equity | (0.06) | (0.04) | (0.05) | 0.00 | |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating CF/Net income | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capex/Depreciation | 0.00 | 0.00 | 0.00 | — | |
| Intangible Assets out of Total Assets | 0.71 | 0.81 | 0.18 | 0.02 | |
| Share Based Compensation of Revenue | — | 0.00% | — | 0.00% | |
| Free Cash Flow Yield | — | — | — | — | |
| Operating CF per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capex per Share | 0.00 | — | 0.00 | — | |
| Free Cash Flow per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Shareholders Equity per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Debt per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Book value per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | (6.28) | (5.49) | (8.60) | (6.26) | |
| Working Capital | (12.89) | (8.54) | (5.91) | 29.94 | |
| Capital Expenditures | 0.00 | — | 0.00 | — | |
| Net Current Asset Value | (16.69) | (11.93) | (6.11) | 29.76 | |
| EV/EBIT | — | — | — | — | |
| Capex to Sales | 0.00 | — | 0.00 | — | |
| Other line items | |||||
| Average Receivables | 1.31 | 0.27 | 1.34 | 1.32 | |
| Average Payables | 6.30 | 4.44 | 4.73 | 5.12 | |
| Average Assets | 19.76 | 14.99 | 11.42 | 31.28 | |
| Average Common Equity | 3.48 | 2.57 | 1.37 | 16.97 |
Columns are period end dates